To evaluate the downstaging rates in hepatitis C virus-patients with hepatocellular carcinoma (HCC), treated with degradable starch microspheres transcatheter arterial chemoembolization (DSM-TACE), to reach new-Milan-criteria (nMC) for transplantation.
Orlacchio, A., Chegai, F., Merolla, S., Francioso, S., Del Giudice, C., Angelico, M., et al. (2015). Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization. WORLD JOURNAL OF HEPATOLOGY, 7(12), 1694-1700 [10.4254/wjh.v7.i12.1694].
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization
ORLACCHIO, ANTONIO;FRANCIOSO, SIMONA;ANGELICO, MARIO;TISONE, GIUSEPPE;SIMONETTI, GIOVANNI MARIA EGISTO
2015-01-01
Abstract
To evaluate the downstaging rates in hepatitis C virus-patients with hepatocellular carcinoma (HCC), treated with degradable starch microspheres transcatheter arterial chemoembolization (DSM-TACE), to reach new-Milan-criteria (nMC) for transplantation.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Downstaging disease_WJH.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
1.39 MB
Formato
Adobe PDF
|
1.39 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
